OHMEGA/MONSTER

Article

Meth in Australia is stronger for the money as deaths hit a record

Police seized record amounts in 2024 but consumption also hit a high worth $8.9 billion, and the link between stronger-for-the-money supply and rising harms is plausible but not proven as cause.

Australia

Updated 2026-09-27: Two date phrases were reworded for clarity (now 'the 12 months to August 2024'). No facts changed.

Pictures in this frame are AI-generated, not photographs.

What happenedAustralians consumed a record 12.8 tonnes of methamphetamine in the 12 months to August 2024 while police seized more than 16 tonnes, as deaths, hospitalisations and wastewater traces all hit highs.

Why it mattersIt explains why record seizures have not stopped record harms, who is most affected — men 35 to 54 and First Nations peoples — and where evidence for cutting deaths is strongest and where it is limited for stimulants.

Still openWhether cheaper, purer supply caused the rise in deaths or how much reflects crystal dominance, more frequent use and mixing drugs — the pattern is correlational with a plausible mechanism, not a measured causal effect.

a wastewater treatment plant with circular tanks at dusk
AI-generated illustration — not a photograph of this story

Methamphetamine — sold in Australia mostly as crystal meth or ice — has become stronger for the money and easier to find, even as deaths, hospitalisations and wastewater traces all hit record highs in 2024. Most deaths were unintentional and concentrated among men in mid-life.

Drug-induced deaths in Australia each year, and how many involved stimulants. Australia recorded 2,596 drug-induced deaths in 2024, the highest in this series, while deaths involving amphetamine-type stimulants reached 843. The final two years are preliminary and may rise; the 1,307 road-death line is the comparison reported with the 2024 overdose figures. — AI-assisted analytic, built only from real cited or sourced data. Source: Junee Southern Cross (syndicating Australian Associated Press / NDARC), Penington Institute. As of 2026-02-15. Partly unconfirmed: 12 of 12 data points could not be confirmed against a source.

The picture comes from two long-running national trackers: the National Wastewater Drug Monitoring Program, run by the Australian Criminal Intelligence Commission, the federal agency that tracks organised crime, and overdose and drug-trend reporting led by the National Drug and Alcohol Research Centre at UNSW Sydney and the Penington Institute, a Melbourne-based public-health research group.

More meth, despite record seizures

What changed is scale. The Commission estimates Australians consumed about 22.2 tonnes of four major illicit drugs in the 12 months to August 2024, up 34% as the market recovered after COVID and organised crime groups re-established and expanded. Methylamphetamine — the chemical name for methamphetamine — rose 21% to a record 12.8 tonnes.

Police seized more than 16 tonnes of methamphetamine in 2024, and for several major drugs the amount seized exceeded the amount estimated to have been consumed. The street value of the four drugs consumed in that wastewater year was put at $11.5 billion, with methylamphetamine accounting for $8.9 billion, about three-quarters.

Researchers say meth has fallen in price once purity is taken into account — in effect, stronger for the same money — and people who use drugs report it remains readily available. There is no published dollar-price and purity series by state or form, and no estimate of how much a price fall lifts use or deaths, so that is best read as a direction, not a precise drop. Australia is described as having one of the highest recorded rates of methamphetamine use in the world, which leaves it highly exposed when global supply expands.

There are two ways to read that cheaper, purer supply. One is that enforcement has failed to constrain availability. The other, which the Commission emphasises, is that a highly profitable global market is outpacing interdiction despite record seizures. In that view, seizures exceeding consumption for some drugs and large joint operations show real disruption that can create windows for demand and harm measures, rather than simply proving supply control does not work.

Record harms, mostly unintentional

The human cost in 2024 was the highest on these measures. Penington put drug-induced deaths at 2,596, the highest on record and about 11% above 2,345 in 2023 — about seven a day. More than 2,000 were unintentional, the first time that threshold has been passed in its 24-year series, representing about 77,000 years of potential life lost, or about 31 years per person who died.

Stimulants were involved in 843 deaths, behind opioids and ahead of benzodiazepines, with more than one drug often involved. More than 750 deaths involving amphetamine-type stimulants, primarily methamphetamine, occurred at a rate of 2.9 per 100,000, up from around 2 per 100,000 in 2021-2023. Methamphetamine-related hospitalisations and wastewater-measured consumption were also at the highest observed levels. Most methamphetamine-related deaths were unintentional.

Harms are not evenly spread. Most methamphetamine-related deaths involved men aged 35 to 54. Over two decades harm has shifted to older age groups, with mortality rising since 2005 among people aged 25 to 54. At the population level, drug-induced deaths are among the leading causes of death for Australians in their 20s, 30s and 40s.

First Nations peoples — Aboriginal and Torres Strait Islander peoples — carry a disproportionately high burden of unintentional drug-induced deaths, and that disparity has widened sharply in recent years, which Penington flags as a national policy priority.

How to read the numbers needs care. The amphetamine-type stimulant counts are reported via syndication of the Research Centre's findings rather than directly from published tables. The headline total also differs by definition: the Australian Institute of Health and Welfare, the federal health statistics agency, consolidates 1,948 drug-induced deaths in 2024, compared with Penington's 2,596, due to different case definitions and coding. The link between cheaper, purer meth and rising deaths and hospitalisations is presented without control for confounders — including the shift from powder to crystal, more frequent use and use of multiple drugs together — so it is a correlational pattern with a plausible economic mechanism, not a quantified causal effect. Wastewater monitoring since 2016 provides a consistent longitudinal signal now at a record, and the upward trajectory in deaths and consumption pre-dates COVID-19.

Why there is no quick fix for meth

The Research Centre calls for a strong, coordinated response involving prevention, harm reduction, treatment access and ongoing monitoring. Penington notes that harm-minimisation efforts in several states and territories — including supervised injecting sites, drug checking and naloxone access — are succeeding where implemented but remain small-scale, accounting for about 2% of drug-policy funding on Penington's estimate, a figure contested as a framing device.

What can be promised for methamphetamine specifically is limited. Unlike opioids, where naloxone can reverse an overdose, there is no equivalent reversal agent for methamphetamine; care is supportive and engagement-based. Evidence for supervised injecting sites and drug checking is strongest for preventing opioid overdose and detecting contaminants, with more limited direct evidence that these interventions reduce methamphetamine deaths at population scale.

Treatment demand signals the need. Publicly funded alcohol and other drug treatment services provided about 244,000 treatment episodes to about 128,000 people aged 10 and over in 2024-25; alcohol was the principal drug of concern in 41% of episodes, methamphetamine second at 24%. Penington's recommended National Overdose Prevention Strategy spans education, naloxone, treatment access and drug checking. While naloxone is opioid-specific, the broader principles — early intervention, reducing harms from an unregulated supply and accessible treatment — are cited as relevant to stimulant harms where no reversal exists.

Australia's official framework is the National Drug Strategy 2017-2026, built on three pillars — demand reduction, supply reduction and harm reduction. Federal and state and territory laws prohibit possession and supply of illegal drugs including methamphetamine, but research with people who use drugs suggests illicit drugs remain readily available, indicating supply reduction alone has not constrained availability.

The supply-reduction and fiscal-sceptic case, steelmanned, runs like this: record consumption and cheaper, purer meth reflect a profitable global market where organised crime recovered after COVID and is outpacing interdiction, not proof that harm reduction has failed or that enforcement is pointless. Record seizures and joint operations show disruption that hinders criminal networks and creates windows for demand-reduction strategies. Reallocation toward harm reduction must weigh opportunity costs, recurrent costs, workforce and regulatory barriers to national scale-up, and the fact that for methamphetamine there is no naloxone equivalent and evidence for supervised consumption and drug checking is strongest for opioids and contaminants.

That tension — between a public-health case that deaths are largely unintentional and preventable and that coordinated harm reduction, treatment and monitoring reduce deaths where implemented, and a three-pillars case that supply disruption is real but insufficient against a glut and that scaling harm reduction nationally involves costs and limits, especially for stimulants — is the policy debate the record numbers force. Both sides point to the same market facts; they differ on what levers move deaths most, and how quickly.

Behind each number are people, families and communities. Health services encourage early help-seeking without judgement. People who use methamphetamine, families and friends seeking information or support can contact the National Alcohol and Other Drug Hotline on 1800 250 015 for free and confidential advice, or Lifeline on 13 11 14 for crisis support.

Source recordSources / claims / limits

How this piece is framed: A cheaper, more available drug meets record harm — the market glut, the human cost, and what evidence says could reduce deaths

Charts & tables — AI-assisted; provenance on each line

  • Drug deaths hit a record in 2024 after two decades of rise — sourced for this figure · as of 2026-02-15 · ⚠ Partly unconfirmed: 12 of 12 data points could not be confirmed against a source.

Visuals not shipped — planned but not fulfilled

  • Australians consumed more meth even as seizures hit records (req_consumption_seizure_02): skipped — # Skipped

The requested combined 2016–17 to 2023–24 chart cannot be built faithfully from the named primary sources.

ACIC’s Report 24 provides the exact national methylamphetamine wastewater estimates (8,405 kg, 9,847 kg, 11,516 kg, 11,147 kg, 8,838 kg, 9,018 kg, 10,585 kg, and 12,815 kg for Years

Sources

Claims, and how far we tracked each down

  • [confirmed] More than 750 overdose deaths involving amphetamine-type stimulants, primarily methamphetamine, occurred in Australia in 2024 · read in full (as of 2026-09-24)
  • [confirmed] The rate of deaths involving amphetamine-type stimulants was 2.9 per 100,000 people in 2024, substantially higher than around 2 per 100,000 in 2021-2023 · read in full (as of 2026-09-24)
  • [confirmed] Methamphetamine-related hospitalisations in Australia are at the highest observed levels · read in full (as of 2026-09-24)
  • [confirmed] Wastewater-measured methamphetamine consumption in Australia is at the highest observed levels · read in full (as of 2026-09-24)
  • [confirmed] The price of methamphetamine in Australia has declined somewhat, particularly relative to purity · read in full (as of 2026-09-24)
  • [confirmed] Authorities seized more than 16 tonnes of methamphetamine in Australia in 2024, significantly more than in previous years · read in full (as of 2026-09-24)
  • [confirmed] Most methamphetamine-related deaths in Australia involved males aged 35-54 years and were unintentional · read in full (as of 2026-09-24)
  • [confirmed] Between August 2023 and August 2024, an estimated 22.2 tonnes of methylamphetamine, cocaine, heroin and MDMA was consumed in Australia, a 34% increase from the previous year, driven by a 21% increase in methylamphetamine consumption · read in full (as of 2026-09-24)
  • [confirmed] Drug-induced deaths in Australia reached 2,596 in 2024, the highest level on record, a 10.7% increase from 2,345 in 2023, equating to about 7 deaths per day · read in full (as of 2026-09-24)
  • [confirmed] Unintentional drug-induced deaths in Australia surpassed 2,000 for the first time in 2024, reaching the highest rate in the 24-year data series · read in full (as of 2026-09-24)
  • [confirmed] First Nations people in Australia experience a disproportionately high burden of unintentional drug-induced deaths, and that disparity has widened in recent years · read in full (as of 2026-09-24)
  • [likely] Evidence-based approaches that reduce drug-related deaths include prevention, harm reduction (including supervised consumption, drug checking and access to naloxone where relevant), treatment access, and ongoing monitoring · read in full (as of 2026-09-24)
  • [confirmed] ACIC Report 24 (Aug 2023-Aug 2024) found 22.2 tonnes of methylamphetamine, cocaine, heroin and MDMA consumed in Australia, a 34% increase year-on-year, driven by methylamphetamine +21%, cocaine +69%, MDMA +49% and heroin +14%, based on 61 wastewater plants covering ~57% of population · read in full (as of 2026-09-24)
  • [confirmed] AIHW reports publicly funded alcohol and other drug treatment services provided ~244,400 treatment episodes to ~127,800 people aged 10+ in 2024-25; alcohol was principal drug of concern in 41% (87,600 episodes), methamphetamine was second at 24%, followed by cannabis 14% and heroin 4.3% · read in full (as of 2026-09-24)
  • [confirmed] AIHW consolidated reporting records 1,948 drug-induced deaths and 1,765 alcohol-induced deaths in 2024, and ~177,000 alcohol and other drug-related ambulance attendances in 2024, differing from Penington's 2,596 drug-induced deaths due to different case definitions/coding; ABS Causes of Death 2024 is the authoritative source for underlying-cause mortality and now publishes revised 2022-2024 data via separate 'Deaths from external causes' tables · read in full (as of 2026-09-24)
  • [confirmed] The association between falling methamphetamine price relative to purity and rising deaths/hospitalisations is presented as correlational with plausible economic mechanism, not quantified causal effect: retrieved primary sources (ACIC wastewater, AIHW harms) provide supply/consumption and harms trends but no price-purity time series by jurisdiction/form, no elasticity estimate, and no confounder control; confounders noted in primary sources include crystal vs powder shift, more frequent use, and polysubstance involvement (opioids 1,083, stimulants 843, benzodiazepines 696 in same deaths) · read in full (as of 2026-09-24)
  • [likely] Primary NDARC Drug Trends 2024/2025 IDRS/EDRS report PDFs and ABS Causes of Death detailed tables (3303.0) for amphetamine-type stimulant deaths (>750, 2.9/100k) and methamphetamine-related hospitalisations at highest observed levels were not extractable via available crawler (NDARC returned generic template, PDFs 404; ABS detailed downloads returned 404/thin landing); those specific figures remain dependent on AAP syndication via src_3f0baba429 pending direct table retrieval · read in full (as of 2026-09-24)
  • [confirmed] ACIC frames rising consumption through supply-reduction/organised-crime lens: 34% rise to 22.2 tonnes (methylamphetamine +21% to record 12.8 tonnes) reflects in part post-COVID market recovery with transnational and domestic groups rapidly re-establishing and expanding operations, requiring concerted coordinated effort under the three pillars of the National Drug Strategy: demand reduction, supply reduction and harm reduction. · read in full (as of 2026-09-24)
  • [confirmed] In 2023-24 the Australian Border Force and Australian Federal Police seized 33.7 tonnes of illicit drugs and precursors at the border and across Australia; for a number of major drugs quantities seized exceeded amounts consumed, hindering criminal networks' ability to grow and expand and creating windows of opportunity for demand-reduction strategies. ACIC estimates street value of the four drugs consumed Aug 2023-Aug 2024 at $11.5 billion, with methylamphetamine accounting for $8.9 billion (78%). · read in full (as of 2026-09-24)
  • [confirmed] AFP-led coordinated enforcement demonstrates ongoing supply-reduction activity: joint Australia-New Zealand week of action 14-18 Sep 2026 (ANZIDWG) charged 1,203 people with 3,339 offences, executed 560 search warrants, and seized 254kg methamphetamine, 16kg heroin, 11.7kg cocaine, 4.6kg MDMA, 10kg ketamine, 716kg cannabis plus 8,701 plants, $2.05m cash and 71 firearms; AFP alone seized 68kg including 8.4kg methylamphetamine and 11.4kg heroin, framed as disrupting availability to reduce harms amid continued strong demand shown in wastewater data. · read in full (as of 2026-09-24)
  • [confirmed] Australia's official policy framework is the National Drug Strategy 2017-2026 built on three pillars — demand reduction, supply reduction and harm reduction (harm minimisation) — as summarised in AIHW's policy-context synthesis; AIHW notes federal and state/territory laws prohibit possession/supply of illegal drugs including methamphetamine, but research with people who use drugs suggests illicit drugs remain readily available from friends/relatives, dealers and online, indicating supply-reduction alone has not constrained availability. · read in full (as of 2026-09-24)
  • [likely] The 2% harm-minimisation funding figure cited via Penington (Queensland, ACT, NSW, Victoria — supervised injecting, drug checking, naloxone) is contested as a framing device: government and law-enforcement sources present funding as balanced across three pillars by design, with supply-reduction (border, AFP/ABF, state police) and demand-reduction (treatment, prevention) constituting the larger shares; critics of harm-reduction scale-up argue reallocation debates must weigh opportunity costs and that expanding supervised consumption/drug-checking nationally involves significant recurrent costs, workforce and regulatory barriers. · read in full (as of 2026-09-24)
  • [likely] Evidence limits for stimulant-specific harm reduction qualify the consensus claim: unlike opioids where naloxone provides a reversal agent, no equivalent pharmacological reversal exists for methamphetamine where supportive care and engagement are the mainstays; the evidence base for supervised injecting sites and drug checking is strongest for opioid overdose prevention and contaminant detection (e.g., nitazenes), with more limited direct evidence that these interventions reduce methamphetamine deaths at population scale. · read in full (as of 2026-09-24)
  • [likely] Alternative interpretation of falling price relative to purity: price decline coinciding with record seizures and record wastewater consumption is more consistent with a global supply glut and post-COVID market re-expansion overwhelming interdiction than with enforcement failure alone; ACIC attributes increase to criminal groups re-establishing operations and evolving trafficking methods, noting seizures exceeding consumption for some drugs — suggesting enforcement is disrupting supply but not sufficient to offset supply surge. · read in full (as of 2026-09-24)
  • [confirmed] Crystal methamphetamine has become increasingly dominant in Australia while powder methamphetamine has dropped in popularity among people who regularly use drugs · read in full (as of 2026-09-24)
  • [confirmed] Methamphetamine-related harm has shifted to older age groups over the past two decades, with mortality rates increasing since 2005 among people aged 25-34, 35-44 and 45-54 · read in full (as of 2026-09-24)
  • [confirmed] Australia continues to have one of the highest recorded rates of methamphetamine use in the world · read in full (as of 2026-09-24)
  • [confirmed] The National Wastewater Drug Monitoring Program covers about 55-57% of the Australian population and has operated since 2016, providing longitudinal consumption estimates · read in full (as of 2026-09-24)
  • [confirmed] In 2024, the most common drugs involved in drug-induced deaths were opioids (1,083 deaths), stimulants (843) and benzodiazepines (696) · read in full (as of 2026-09-24)
  • [confirmed] The National Alcohol and Other Drug Hotline (1800 250 015) provides free and confidential advice, information and counselling about alcohol and other drugs in Australia · read in full (as of 2026-09-24)

Where we hit a limit / what to double-check

  • Figures we could not match to our stored evidence — worth confirming against the source (which may state them exactly), and note live sources move: 11%.